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Biological robustness is a principle that may shed light on
system-level characteristics of biological systems. One
intriguing aspect of the concept of biological robustness is
the possible existence of intrinsic trade-offs among robust-
ness, fragility, performance, and so on. At the same time,
whether such trade-offs hold regardless of the situation
or hold only under speciﬁc conditions warrants careful
investigation. In this paper, we reassess this concept and
argue that biological robustness may hold only when a
system is sufﬁciently optimized and that it may not be
conserved when there is room for optimization in its
design. Several testable predictions and implications for
cell culture experiments are presented.
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Introduction
It has been claimed that trade-offs exist between robustness,
fragility, performance,and resourcedemandsin biologicaland
engineering systems (Csete and Doyle, 2002; Kitano, 2004,
2007). Determination of the conditions in which this con-
jecture would hold is of great interest for systems theory in
biology. For example, systems that are optimized to be robust
against certain perturbations are often extremely fragile
against unexpected perturbations.This trade-off is also known
as the ‘robust yet fragile’ nature of highly optimized systems
(Csete and Doyle, 2002). Principles such as the Bode integral
formula (Bode, 1945) and the summation theorem in meta-
bolic control analysis (Fell, 1997) underscore this trade-off in
certainconditions.Althoughsuchtheoremsprovideabasisfor
understanding robustness trade-offs, their applications are
limited to speciﬁc aspects of the system. The Bode integral
formula applies speciﬁcally to conservation of the sensitivities
of negative feedback circuits on a frequency axis, and the
summation theorem assumes linearization for minor pertur-
bations. In addition, real systems are likely to exhibit more
complex robustness–fragility trade-offs because of the invol-
vement of component failures and other aspects not taken into
account for these theorems (see Supplementary information).
Such trade-offs may thus hold only when design and
implementation are sufﬁciently optimized. This means that
the system can be made more robust without undermining
other features (see Box 1). It should be noted that the system
can be optimized by redesign and reimplementation of
engineering systems. In biological systems, an evolutionary
selection is required for such design optimizations. Although
qualitative observations exist for this trade-off, quantitative
experimental veriﬁcation of this trade-off has not been
conducted.
In contrast, the trade-off between robustness and perfor-
mance is more tractable, and several experimental and
computational reports discussing such a trade-off have been
published (Ibarra et al, 2002; Stelling et al, 2002; Fischer and
Sauer, 2005; Andersson, 2006). In short, the trade-off dictates
that high-performance systems are often more fragile than
systems with suboptimal performance. Interestingly, there are
studies reporting suboptimal metabolism performance in
Bacillus subtilis and Escherichia coli (Stelling et al, 2002;
Fischer and Sauer, 2005). If the trade-off holds, metabolic
performance has to be kept suboptimal to ensure a certain
level of robustness against environmental perturbations.
As such studies observe cultured microorganisms and cells,
changes in performance and robustness can be attributed to
either of the two scenarios: emergence and rebalancing. The
emergence scenario assumes that random mutation gives rise
to a genetic subtype that ﬁts the perturbed environment better
and that this subtype quickly proliferates in culture. The
rebalancingscenarioassumesthataspeciﬁcmutantstrainthat
ﬁts the environment better may already exist in a hetero-
geneous population even before perturbations are imposed,
and that this strain proliferates faster than other strains under
the perturbed environment.
It is important to clearly deﬁne robustness and adaptation
through evolutionary selection. Here, ‘robustness’ means an
individual organism’s capability of tolerating external and
internal perturbations, such as environmental ﬂuctuations,
the addition of drugs, and mutations. Robustness–perfor-
mance trade-off means that, when two individuals are
compared, one is found to be more robust than the other but
is outperformed by the other; thus, no individual can be more
robust and at the same time exhibit higher performance than
others. In general, organisms can be ‘optimized’ or ‘adapted’
to a certain condition by evolutionary selection; thus, they
can be more robust against perturbations implicated in the
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preselected individuals. Thus, if the robustness–performance
trade-off holds, descendents of organisms can be more robust
than their ancestors when they are adapted for perturbations
imposed during evolutionary selection, but they may be
outperformed by their ancestors or by other individuals
adapted for other conditions in which performance is favored.
By the same token, the descendents of organisms can
outperform their ancestors when selection pressure favors
high-performing individuals, but may be less robust than their
ancestors and other individuals evolved under conditions that
favor more robust individuals.
In this paper, we examine the idea that such trade-offs
appear only when the system is sufﬁciently optimized,
and thus may not be observed when systems are yet to be
fully optimized. This implies that there should be cases in
which descendents of organisms can be more robust and
perform as well as or better than their ancestors, which is
not possible if robustness–performance trade-off holds uni-
versally.
A primer on portfolio selection
In this article, the portfolio selection concept used in modern
investment theory is introduced to explain robustness–per-
formance trade-offs. Portfolio selection is an idea to combine
various investment options to minimize risk while attaining
the desired return on investment (Markowitz, 1991). In the
modern portfolio theory used in investment practice, it is well
understood that there is trade-off between risk (uncertainty of
the return shown by s.d.) and performance (expected return).
High-yield ﬁnancial products generally have higher risk, and
modest-yield products have lower risk. Risk in this context
refersto the s.d.of theasset price. Performance is measured by
theexpectedpercentageofreturn.Anyinvestmentitem(asset)
can be mapped on a yield–risk space.
As investors generally invest in multiple ﬁnancial assets
with different expected yields and risks, the question is how to
ﬁnd the optimal mix of assets with a desirable yield and
acceptable risk. The concept of efﬁcient frontier needs to be
introduced here. The efﬁcient frontier is a set of points that
represent an optimal combination of assets (mostly securities
in a ﬁnancial context) that maximizes the return for any
given level of s.d. Any point not on the efﬁcient frontier
represents a portfolio that is inferior to a portfolio on the
efﬁcient frontier, either because it generates less return at the
same level of risk or is exposed to higher risk at the same
expected level of return. In Figure 1A, Portfolio X is inferior to
both Portfolios Y and Z. Portfolio Y has a higher expected
return than X at the same level of risk, and Z has lower risk
than X with the same expected return. Portfolio X can be
reorganized to reach the efﬁcient frontier. Thus, theoretically,
any portfolio not on the efﬁcient frontier can improve its yield
without increasing risk, or reduce risk without undermining
the expected yield. However, on the efﬁcient frontier, any
change in yield affects risk and vice versa. Trade-off between
risk and yield takes place on an optimal portfolio that is on the
efﬁcient frontier. A similar trade-off concept is also investi-
gated in the context of multiobjective optimization as the
Pareto efﬁciency, originally proposed by Pareto (1935). For a
Pareto-efﬁcient solution, no individual parameter can
be improved without undermining another parameter. A set
of Pareto-efﬁcient solutions constitute a Pareto surface, also
called a Pareto frontier.
An indifference curve projects valuation criteria on the
yield–risk space. It has graded utility levels depending on
The robustness–fragility trade-off is one of the most widely known trade-offs for biological and engineering systems. A simple toy example using electric circuits is
presentedheretoshowthatthetrade-off holdsonlywhensystemdesignandimplementationaresufﬁcientlyoptimized.Inotherwords,acircuitcanbemademore
robust without scarifying other features.Take a simple electronics example: Assume a simple feedback ampliﬁer in which a feedback loop consists of resistors
(DesignA).Thereisclearlyarobustness–fragility trade-offduetothefeedbackloop,asdepictedintheBodetheorem(Bode,1945).Withoutaffectingthetrade-off
due to the feedback, the actual implementation of the ampliﬁer can be changed to have two serially connected resistors in its feedback loop (Design B). Failure of
oneoftheseresistersmaycausedysfunctioninthefeedbackloopandunderminethesystemstability.Alternatively,theuseofresistorsconnectedinparallelwould
reduce such a failure risk (Design C). The parallel implementation is more robust against component failure than both a single and a serial connection
conﬁguration.AssumingthataprobabilityoffailureofeachresisterisP,DesignBissusceptivetocomponentfailure,asaprobabilityoffailureofthefeedbackloop
simplydoubles(2P).DesignAreducessucharisktohalfofthatofDesignBbecauseitonlyusesoneresister;hence,probabilityoffailureisP.DesignCimproves
robustnessagainstcomponentfailureonfeedbackloopsbecauseofparallelconstruction.NowithasonlyP
2,whereasresourcedemandisequivalenttoDesignB.
Forexample,adesignchangefromDesignBtoDesignCimprovestherobustnessofthesystemagainstcomponentfailureswithoutincreasingfragilityelsewhere,
underminingperformance,orrequiringmajoradditionalresources.Thus,robustnessisimprovedwithoutsubstantialtrade-offs.ChangefromDesignBtoAactually
reduces resource demands slightly and improves robustness. Change from Design A to C improves robustness with minimum increase in resource demands.
However, attempts to totally eliminate component failure, not only for a feedback loop but for every aspect of the system, would require multiple redundancies for
every aspect of the system, which would require major resources. How design affects the system vulnerability to component failure is a complex issue, and
biological cases need to be further explored. It will be further complicated when feedback loops are involved (see Supplementary information).
Box 1 Design suboptimality and robustness–fragility trade-offs
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risk preference. A risk-aversion indifference curve represents
a portfolio chosen to maximize the expected return but
avoids risk (Figure 2A). A risk-neutral indifference curve is
used when only the expected return is considered (Figure 2B).
Arisk-preferenceindifferencecurveisusedwhenhigherriskis
preferred for an equal expected return (Figure 2C). Obviously,
the risk-preference indifference curve would be an odd choice
for an investment situation. Thus, the risk-aversion indiffer-
ence curve is used in general.
Genetic portfolio selection: translating
investment theory into biology
Portfolio selection, which seems remote from biology, can be
applied to understand the evolution of microorganisms and
cells in speciﬁc conditions. Thus, it may help us understand
robustness–performance trade-offs.
Each organism or cell can be mapped onto the yield–risk
space. A position of the yield–risk space that characterizes the
biological entity X can be called ‘a projected position of X.’
Yield is an expected performance, such as reproduction speed
or biomass production rate. Risk (equivalent to fragility) is the
degree to which a growth rate or biomass production rate is
affected by perturbations. In general, it can be represented by
s.d. and calculated by assuming possible perturbations, their
probabilities of occurrence, and expected yield under each
perturbation (Box 2). These indexes can be measured by
tracing behaviors of individual cells and their biomass
productionorlineageforreproductiveefﬁciencyundervarious
conditions. Alternatively, they can be measured by the growth
of the population under various perturbations in which the
population can be kept monoclonal. In this case, the
distribution of projected positions of a certain cell or organism
Figure 2 Indifference curves. Three indifference curves are shown: (A) risk-aversion, (B) risk-neutral, and (C) risk-preference curves. Percentile numbers associated
with each line indicate the level of utility, hence the level of satisfaction or optimality in the given context.
Figure 1 Basic concepts of portfolio selection. (A) Any asset can be mapped on the E(r)–s(r), or yield–risk, space. Combining A and B creates a possible space of
yield and risk depending on the mixture and covariance of the two assets against ﬂuctuation. Maximum risk reduction is achieved when the prices of the two assets
change in opposite directions because this offsets ﬂuctuation. Increasing the number of assets involved generally reduces risk. The efﬁcient frontier is achieved by
optimally combining all available assets. Availability of a larger number of assets with different yield–risk characteristics improves the overall portfolio, analogous to an
increase in the degree of design of freedom in highly optimized tolerance (Carlson and Doyle, 1999; Reynolds et al, 2002). In actual investment planning, investment
withaﬁxedreturn asset isconsidered toforma capitalmarket line,but thisisnot considered inbiological applications because thereis nozero-risk-ﬁxed-yieldgenotype.
(B) The probability distribution of expected return is shown for each asset and portfolio in (A) to visually illustrate their relationships.
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is contained by the efﬁcient frontier (Figure 3). Changes
in the distribution of projected positions in the yield–risk
space for randomly sampled cells will test the conjecture
that the robustness–performance trade-off holds only at the
efﬁcient frontier.
Next, we consider the cases in which such a trade-off holds in
a population of microorganisms and cells. Analysis at the
population level is biologically important because cell cultures
that have a substantial level of heterogeneity are often used in
biological experiments. In addition, certain tumors are known to
be composed of heterogeneous cancer cells. Furthermore,
populations of organisms and cells are used to measure growth
rate and how organisms respond to environmental changes in
the context ofthe studyof general biologyandin drugscreening.
Growthrate(yieldorperformance)isgenerallymeasuredby
thesizeofacolony,bynumbersofcells,orbyothermeansthat
reﬂect the number of cells in the population. Risk is an s.d. of
growth rate under various possible perturbations. Experimen-
tally, it can be measured by repeated perturbation experi-
ments. In a heterogeneous cell culture, the projected position
of the cell culture in the yield–risk space is determined by
the population composition. This is illustrated in Figure 4.
Initially, the cell culture is mainly composed of subtypes
AandB,withanegligibleamountofC(Culture1inFigure4A).
Subtype C has a better ﬁt with the culture condition and has
Suppose the yield is the growth of an organism. Expected yield and its s.d. can be determined through a series of perturbation experiments. For example, the
growth rate of each subtype may be measured under a normal culture condition (no perturbation or reference) and with different perturbations (A). Selection is
imposed atanindividuallevel.Histograms (B)indicate thenumber ofcellsthatresultincelldeath,nondividingcellsafteracertainperiodof time,anddividingcells
with different intervals for subtype A under different conditions. Expected yields in (A) are the results of such responses of individual cells for each
condition.Subtypes can be mapped on the yield–risk space as shown in (C). Under the condition that 80% of the time there is no perturbation and 20% of the time
perturbation1occurs,eachsubtypecanbemappedontheyield–riskspaceasshownbyredsymbols.Inthiscase,acombinationofsubtypesBandCreducesrisk
without major sacriﬁce in yield. Because of the covariance of B and C that has a very small positive value (0.068), mitigation of risk over the risk of subtype B is
limited. The projected position of each subtype in the yield–risk space will be different if assumed perturbations and their probability of occurrence are different.
Undertheassumptionofnoperturbationandperturbation1conditions,eachwitha50%probability,theprojectedpositionofeachsubtypeintheyield–riskspaceis
shownbybluesymbols,whichare locateddifferently fromthe redsymbolsthatassume noperturbationfor80%probability. Theexpected yieldsofsubtypesBand
C are now equal; thus, a combination of B and C only reduces risk, yield is not reduced. Yet another assumption of perturbations, in which no perturbation and
perturbations 1, 2, 3, and 4 each occur with 20% probability, would result in each subtype being located as shown by the green symbols. In this case, subtypes A
and C suffer seriously from perturbations; thus, the population will be dominated by subtype B, which has robust yet low-yield characteristics.
Box 2 Mapping cell culture onto yield–risk space
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that of subtypes A and B (Culture 2 in Figure 4A). Random
mutation gives rise to subtype D. It has higher reproductive
potential under this speciﬁc culture condition, and thus it
quickly proliferates in the population (Culture 3 in Figure 4A).
However, when extra perturbations are imposed on the
culture, fast-growing but less-robust subtypes (subtype D)
may substantially decrease in their proliferation speed or the
number of cells. At the same time, low-yield but more-robust
subtypes may continue to grow at a similar rate. These
population changes result in a composition that better ﬁts a
condition with a higher degree of perturbations. In this case,
the projected position of the culture on the yield–risk space
map may move left to that of Culture 4 in Figure 4A. In
contrast, the fast-growing subtype may establish its dom-
inance when the environment reaches a more stable condition
that is ideal for the fast but less-robust subtype (Culture 5 in
Figure 4A). Both emergence and rebalancing scenarios are
included, but for the sake of explanation, only the wild type
and its mutational variants are used as subtypes. However,
cells with different epigenetic modiﬁcations can be considered
as subtypes if these modiﬁcations affect the yield–risk
characteristics of the cell.
Althoughtranslationofportfoliotheoryforbiologyisshown
to be possible, some clear and essential differences have to be
made explicit and given a new interpretation that is consistent
with biology. First, portfolio selection assumes that there are
investors and fund managers making decisions regarding the
composition of assets selected for the portfolio. This is clearly
not the case in biology. The population composition changes
because of the relative growth rate of each cell subtype that
is the aggregated effect of individual cell reproduction cycles.
Individual cells and organisms will be the subject of selection.
Second, in portfolio selection theory, investors decide on the
indifference curve to be used on the basis of their appetite for
risk taking. In the biological translation, indifference curves
are only a reﬂection of the level of perturbation imposed on
organismsandcells(Figure4B). Whenorganismsandcellsare
culturedinahighlystationaryenvironment,theuseoftherisk-
neutral curve may best predict their possible evolutionary
paths. Risk-aversion curves represent the situation in which
perturbations are imposed on organisms and cells.
Performance suboptimality and
robustness trade-offs
Studies report that suboptimal metabolism performance exists
in microorganisms such as B. subtilis and E. coli (Stelling et al,
2002;FischerandSauer,2005).FischerandSauer(2005)argue
that several regulatory mutants that have improved biomass
production efﬁciency were ‘almost exclusively regulators of
not-yet-activated adaptive responses, suggesting that B.
subtilis invests valuable resources in anticipation of changing
environmental conditions at the expense of optimal growth’.
As almost all mutations to enhance biomass production
Figure 3 Distribution of randomly sampled cells on yield–risk space. A heterogeneous culture of cells is composed of a mixture of wild type and various mutant cells.
(A) At the initial stage of culturing, random sampling of cells and mapping onto the yield–risk space may result in a broad distribution for the yield and risk of each cell.
(B) Culturing this population under the stationary condition for multiple passages may result in evolution of the culture toward a high-yield genotype. Each circle
represents randomly sampled cells at this time point, and not the same cell sampled in (A), because multiple passages have occurred. (C) Further passages under the
stationary condition result in a distribution strongly favoring high-yield individuals. If there is a trade-off between robustness and performance, hence an inverse of risk
and yield holds, distribution will be constrained within a certain envelope represented by the efﬁcient frontier. Artiﬁcial evolution experiments with random sampling for
yield–risk space mapping test the conjecture of robustness–performance trade-off at the efﬁcient frontier. (D) If the robustness–performance trade-off holds at any time,
evenwithoutbeingatthe efﬁcient frontier, thecenter ofgravityofall randomlysampled points afterpassageswill simplyshifttowardthe upperright.Thiscontrasts tothe
case that the trade-off holds only at the efﬁcient frontier. This difference can be experimentally veriﬁed.
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changes, it is likely that the projected position of B. subtilis is
on the efﬁcient frontier and optimized for the risk-aversion
indifference curve (orange line in Figure 4B), because any
change to increase biomass would be associated with an
increased risk under environmental ﬂuctuations (Trajectory A
in Figure 4B). Thus, although Fischer and Sauer argue that B.
subtilis exhibits suboptimal metabolism, it can be considered
optimal for the risk-aversion indifference curve.
Culturing microorganisms or cells under a chemo-static
laboratory setup may enable the creation of an almost
perturbation-free environment, unless explicitly imposed. In
such a case, a risk-neutral indifference curve can be applied to
determine the optimal portfolio (blue line in Figure 4B). For
example, a population of E. coli evolved in the laboratory may
quickly arrive at one of the projected positions on the efﬁcient
frontier and move along the trajectory of maximum biomass
production through evolution (Ibarra et al, 2002) (Trajectory A
in Figure 4B). The line of optimality in the phenotype phase
plane as shown in Ibarra et al (2002) may correspond to the
efﬁcientfrontierunderstationarycondition.Infact,theirFigure4
shows that the yield of bacteria evolves toward the line of
optimalitythatisconsistentwithFigure3(A–C)inthispaper.qIt
should be noted that the line of optimality does not reﬂect
the risk factor against perturbations. It only illustrates yield
optimization. Therefore, it can be speculated that the E. coli that
achieved maximum biomass production is more fragile against
environmental change than those that have not evolved.
Interestingly, there are studies reporting that some patho-
gens evolve to overcome decreased growth ﬁtness. As a result,
Figure 4 (A)In biological application ofportfolio selection,each individual is mapped on the yield–risk space.A cultureof cells may contain multiple differentsubtypes
withmutationsandepigeneticmodiﬁcations.Assumeacultureofcells(ororganisms)composedofsubtypesA,B,C,andD.Attheinitialstage,AandBmaybedominant
and C and D may be negligible (Culture 1). However, subtype C better ﬁts the environment and grows faster than A and B (Culture 2). Subtype D starts to grow faster
than the others and changes the subtype composition of the culture (Culture 3). At this stage, the composition of the culture may be sufﬁciently optimized for the given
culture condition. Suppose the culture condition is changed now to have greater perturbations. Subtype D may not be able to tolerate it and will decrease the rate of
proliferation and may even reduce in number, and subtype C may grow faster than the other subtypes (Culture 4). Alternatively, subtype D may continue to grow faster
thanother subtypes if the environment becomes evenmore stable.(B)Apopulation of cells may evolve toward the efﬁcient frontier. Underthe risk-aversion indifference
curve, the population arrives at the blue circle on the efﬁcient frontier. The risk-aversion curve represents cases in which higher-level perturbations are imposed on the
culture compared with a risk-neutral case. Under the stable condition in which selection pressures other than growth speed are not signiﬁcant, the risk-neutral
indifference curve is likely to be applied. The population follows Trajectory A and maximizes its growth rate at the cost of robustness. Imposing a higher level of
perturbationmayresultintransitionofthestatethroughTrajectoryB.(C)Cost-freeresistancemay bearesult oftaking TrajectoryEorFtoanewefﬁcientfrontier.There
may be cases in which the population moves back to suboptimal regions (Trajectories G). Chemotherapy for cancer may shift the point inside the efﬁcient frontier with
different end points because of heterogeneous subpopulations. However, tumor cells may again evolve to gain proliferation potential despite the presence of anticancer
drugs (Trajectories H). Tumor cells that undergo this transition may be too optimized for this speciﬁc therapeutic intervention, which implies possible efﬁcacy when
therapeutic regimens are switched. This may explain the collateral sensitivity of drug resistance tumor cells (Skipper et al, 1972).
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growth rate (Andersson, 2006). Although there is controversy
with regard to this concept of ‘cost-free evolution,’ if it is
correct, this compensatory evolution is thought to adapt
to drugs that result in individuals that are more robust
against drug insults, without increasing fragility elsewhere
or undermining system performance measured by growth
rate. In general, pathogens that have acquired drug resis-
tance are known to have less growth ﬁtness than pathogens
without drug resistance. This can be seen as a trajectory
along the efﬁcient frontier, but toward the lower-left direction
in Figure 4B (Trajectory B) and 4C (Trajectory D). Because
oftheexistence ofadrug, pathogensthat areabletoproliferate
under drug exposure grow faster than others. Such patho-
gens may arise because of random mutations that better ﬁt the
drug-exposedenvironment.Asaresult,thepopulationevolves
to be optimal under the strong risk-averse indifference curve.
This implies that trade-offs exist between increased drug
resistance and a competitive growth rate against nonresis-
tant pathogens. Again,‘robustness’ is used as a general term
to deﬁne the organism’s tolerance against perturbations,
including environmental ﬂuctuations, the addition of drugs,
and mutations. Although acquisition of drug resistance
does not affect an organism’s capability to cope with non-
drug perturbations, overall robustness was considered to be
increased because of added tolerance to the drug. Although
the existence of ‘cost-free evolution’ seems to breach the
concepts of robustness–performance trade-off, it is consis-
tent because this is a process of moving toward a new efﬁ-
cient frontier (hence, the population is evolving), and
robustness–performance trade-off can be observed only on
the efﬁcient frontier. The efﬁcient frontier has changed
because of the presence of a drug that was not a factor
in determining the original efﬁcient frontier (Trajectory E or F
in Figure 4C).
Predictions and implications
The application of the concept of portfolio selection to
biological systems results in testable predictions. First, it is
predicted that the growth rate or biomass production of
organisms and cells can be improved through evolution
without increasing fragility until the efﬁcient frontier is
reached. A trade-off emerges only at the efﬁcient frontier. This
canbetestedbyrandomsamplingofcellsinartiﬁcialevolution
experiments under a stationary culture condition, as shown in
Figure 3. By the same token, the growth rate or biomass
production of a population of organisms and cells can be
improved without increasing their fragility against perturba-
tions. Only when the population is on the efﬁcient frontier do
changes in yield and risk affect each other, hence a trade-off
emerges. Therefore, robustness (or fragility) is not always
conserved; it is conserved only when the system is on the
efﬁcient frontier.
Second, once the population or individual cells are on the
efﬁcient frontier and a stable culture condition persists, their
position in the yield–risk space may move along the efﬁcient
frontier to the right for higher yield at the cost of robustness.
This is because of the higher growth rate of a subtype over
others that better ﬁt the condition. Whether the population is
onatrajectorytowardtheefﬁcientfrontierormovingalongthe
efﬁcient frontiercanbedistinguishedbylooking atthetypesof
mutations and upregulation of genes that occur during such
transitions. If the projected position of the population of cells
on the yield–risk space moves toward the efﬁcient frontier
from a suboptimal portfolio space (Trajectory C in Figure 4B),
mutationsandgeneup-ordownregulationscanbeobservedin
broaderfunctionalclassesofgenes.Incontrast,iftheprojected
position of the population of cells on the yield–risk space
moves along the efﬁcient frontier to the right (Trajectory A in
Figure 4B), mutations that generate high-risk high-yield
phenotypes and downregulation of genes that accounts for
perturbations may be observed. Prediction can be tested by
sampling populations of cell and individual cells for sequen-
cing and expression proﬁle measurements to identify distribu-
tion of genes that are affected. In addition, different genes may
be upregulated in a culture condition in which multiple
perturbations are constantly imposed, because this would
push the population to a lower-yield projected position. Genes
that are accountable for environmental perturbations will be
upregulated and genes that attain a higher yield may be
downregulated.
If these conjectures hold and are proven to have wider
applicability, there will be several implications for how we
handle cell culture experiments. Cells cultured for multiple
generations may have the problem of being optimized for
a culture-speciﬁc condition and higher growth rate rather than
for robustness against broader perturbations. Consider the
drug-screening process. Drugs are initially screened using cell
cultures. When a cancer cell line is used, for example, various
drug candidates are applied for various cell lines. Cells in the
culture are those that best ﬁt the speciﬁc culture condition,
which does not necessarily represent an in vivo environment
for tumor cells. The most successful drug candidate may then
be the one that undermines the growth of cells that are
optimized for this speciﬁc condition. As in vivo cancer cells
may be optimized for surviving under various perturbations,
but may not for growth rate, a serious discrepancy exists
between cells used for screening and actual cancer cells. Such
adiscrepancymaybemitigatedifacultureconditioncanbeset
to impose various perturbations mimicking the cancer cells to
which the body may be exposed. Thus, a deeper under-
standing of the type of perturbations that tumor cells in the
body may be exposed to may make it possible to develop a
multiple perturbation culture system that may improve the
screening process.
By the same token, induced stem cells that are screened
for therapeutic purposes may entail a similar problem. Cells
with undermined robustness may be selected in favor of
efﬁcient reprogramming and upregulation of induction and
differentiation markers, rather than cells that maintain
robustness against broader perturbations. Currently, multiple
generations are required for induction of pluripotent stem
cells and elimination of epigenetic traces that are reminiscent
of original cells (Masaki et al, 2007). During this process,
which often requires multiple passages, new epigenetic
modiﬁcations that are introduced by speciﬁc culture condi-
tions are inevitable (Rubin, 1994; Meissner et al, 2008).
It remains to be seen whether characteristics coselected for
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therapeutic use.
With the introduction of the portfolio selection concept,
observed breaches of trade-offs and enigma of performance
suboptimality can be explained. Further studies and veriﬁca-
tions are expected to lead to solid theories for biological
systems and their applications to medical research.
Supplementary information
Supplementary information is available at the Molecular
Systems Biology website (http://www.nature.com/msb).
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